These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21743667)

  • 1. Fluoxetine and vascular headaches.
    Andrade C
    Indian J Psychiatry; 1994 Jan; 36(1):39. PubMed ID: 21743667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effect of converting antidepressant therapy from fluoxetine to sertraline.
    Haider A; Miller DR; Christenson JL; Cushing AG; Station RD
    Am J Health Syst Pharm; 1995 Jun; 52(12):1317-9. PubMed ID: 7656119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of buspirone and fluoxetine in short-term treatment of bulimia nervosa].
    Rajewski A; Rybakowski F
    Psychiatr Pol; 2006; 40(1):75-82. PubMed ID: 16756030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation antidepressants for seasonal affective disorder.
    Thaler K; Delivuk M; Chapman A; Gaynes BN; Kaminski A; Gartlehner G
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008591. PubMed ID: 22161433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and late-onset effect of chronic stress on vascular function in mice: a possible model of the impact of depression on vascular disease in aging.
    Isingrini E; Belzung C; d'Audiffret A; Camus V
    Am J Geriatr Psychiatry; 2011 Apr; 19(4):335-46. PubMed ID: 21427642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression".
    Taragano FE; Bagnatti P; Allegri RF
    Int Psychogeriatr; 2005 Sep; 17(3):487-98. PubMed ID: 16252380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose.
    Beasley CM; Nilsson ME; Koke SC; Gonzales JS
    J Clin Psychiatry; 2000 Oct; 61(10):722-8. PubMed ID: 11078032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of effectiveness of electroacupuncture and fluoxetine for treatment of depression with physical symptoms].
    Duan DM; Tu Y; Chen LP
    Zhongguo Zhen Jiu; 2008 Mar; 28(3):167-70. PubMed ID: 18447212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine-associated stomatitis.
    Palop V; Sancho A; Morales-Olivas FJ; Martínez-Mir I
    Ann Pharmacother; 1997 Dec; 31(12):1478-80. PubMed ID: 9416385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression.
    Lee MS; Ham BJ; Kee BS; Kim JB; Yeon BK; Oh KS; Oh BH; Lee C; Jung HY; Chee IS; Choe BM; Paik IH
    Curr Med Res Opin; 2005 Sep; 21(9):1369-75. PubMed ID: 16197655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine-induced psoriasis.
    Hemlock C; Rosenthal JS; Winston A
    Ann Pharmacother; 1992 Feb; 26(2):211-2. PubMed ID: 1554934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression.
    Beasley CM; Bosomworth JC; Wernicke JF
    Psychopharmacol Bull; 1990; 26(1):18-24. PubMed ID: 2196623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of prenatal depression and stress treatment: alteration on serotonin system of offspring through exposure to Fluoxetine.
    Pei S; Liu L; Zhong Z; Wang H; Lin S; Shang J
    Sci Rep; 2016 Oct; 6():33822. PubMed ID: 27703173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy evaluation for depression with somatic symptoms treated by electroacupuncture combined with Fluoxetine.
    Duan DM; Tu Y; Chen LP; Wu ZJ
    J Tradit Chin Med; 2009 Sep; 29(3):167-73. PubMed ID: 19894377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practice.
    Corne SJ; Hall JR
    Int Clin Psychopharmacol; 1989 Jul; 4(3):245-54. PubMed ID: 2677126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in austria.
    Brown MC; Nimmerrichter AA; Guest JF
    Eur Psychiatry; 1999 Jul; 14(4):230-44. PubMed ID: 10572352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory loss in a patient treated with fluoxetine.
    Joss JD; Burton RM; Keller CA
    Ann Pharmacother; 2003 Dec; 37(12):1800-3. PubMed ID: 14632599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal sumatriptan in post-ECT headache: results of an open-label trial.
    Markowitz JS; Kellner CH; DeVane CL; Beale MD; Folk J; Burns C; Liston HL
    J ECT; 2001 Dec; 17(4):280-3. PubMed ID: 11731730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cocaine-related vascular headaches.
    Dhuna A; Pascual-Leone A; Belgrade M
    J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):803-6. PubMed ID: 1955899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine.
    Walker Z; Walker RW; Robertson MM; Stansfeld S
    Headache; 1998; 38(7):523-8. PubMed ID: 15613168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.